Please assess the completion status of the following clinical trial:

Trial Title: Male Hormonal Contraceptive Development-ACY-5

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males between 18-55~* In good general health~* With normal sperm counts~* Willing to use an acceptable form of contraception~Exclusion Criteria:~* Men in poor health~* Significant chronic or acute medical illness~* Skin conditions that might interfere with or be exacerbated by testosterone gel~* Known history of alcohol, illicit drug or anabolic steroid abuse~* Abnormal reproductive function~* Participation in a long-term male contraceptive study within past three months

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Testosterone (T) gel for 6 months + DMPA (injected into muscle once)on Day 0 and at Month 3
- 2 (Type: ACTIVE_COMPARATOR): Testosterone (T) gel for 6 months + DMPA (injected into muscle on Day 0 \& at month 3) + Acyline (SQ) every two weeks for the first 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).